Mookerjee, S. A., Goncalves, R. L. S., Gerencser, A. A., Nicholls, D. G. & Brand, M. D. The contributions of respiration and glycolysis to extracellular acid production. Biochim. Biophys. Acta 1847, 171–181 (2015).
Wellen, K. E. & Thompson, C. B. A two-way street: reciprocal regulation of metabolism and signalling. Nat. Rev. Mol. Cell Biol. 13, 270–276 (2012).
Weinberg, S. E., Sena, L. A. & Chandel, N. S. Mitochondria in the regulation of innate and adaptive immunity. Immunity 42, 406–417 (2015).
West, A. P. et al. TLR signalling augments macrophage bactericidal activity through mitochondrial ROS. Nature 472, 476–480 (2011).
Lightowlers, R. N., Taylor, R. W. & Turnbull, D. M. Mutations causing mitochondrial disease: what is new and what challenges remain? Science 349, 1494–1499 (2015).
Mishra, P., Carelli, V., Manfredi, G. & Chan, D. C. Proteolytic cleavage of Opa1 stimulates mitochondrial inner membrane fusion and couples fusion to oxidative phosphorylation. Cell Metab. 19, 630–641 (2014).
Ishihara, T. et al. Dynamics of mitochondrial DNA nucleoids regulated by mitochondrial fission is essential for maintenance of homogeneously active mitochondria during neonatal heart development. Mol. Cell. Biol. 35, 211–223 (2015).
Yapa, N. M. B., Lisnyak, V., Reljic, B. & Ryan, M. T. Mitochondrial dynamics in health and disease. FEBS Lett. 595, 1184–1204 (2021).
Rodrigues, T. & Ferraz, L. S. Therapeutic potential of targeting mitochondrial dynamics in cancer. Biochem. Pharmacol. 182, 114282 (2020).
Ong, S. B. et al. Inhibiting mitochondrial fission protects the heart against ischemia/reperfusion injury. Circulation 121, 2012–2022 (2010).
Sharp, W. W. et al. Dynamin-related protein 1 (Drp1)-mediated diastolic dysfunction in myocardial ischemia-reperfusion injury: therapeutic benefits of Drp1 inhibition to reduce mitochondrial fission. FASEB J. 28, 316–326 (2014).
Bernhardt, D., Muller, M., Reichert, A. S. & Osiewacz, H. D. Simultaneous impairment of mitochondrial fission and fusion reduces mitophagy and shortens replicative lifespan. Sci. Rep. 5, 7885 (2015).
McQuibban, G. A., Lee, J. R., Zheng, L., Juusola, M. & Freeman, M. Normal mitochondrial dynamics requires rhomboid-7 and affects Drosophila lifespan and neuronal function. Curr. Biol. 16, 982–989 (2006).
Yang, C. C., Chen, D., Lee, S. S. & Walter, L. The dynamin-related protein DRP-1 and the insulin signaling pathway cooperate to modulate Caenorhabditis elegans longevity. Aging Cell 10, 724–728 (2011).
Fealy, C. E., Mulya, A., Lai, N. & Kirwan, J. P. Exercise training decreases activation of the mitochondrial fission protein dynamin-related protein-1 in insulin-resistant human skeletal muscle. J. Appl. Physiol. (1985). 117, 239–245 (2014).
Youle, R. J. & van der Bliek, A. M. Mitochondrial fission, fusion, and stress. Science 337, 1062–1065 (2012).
Tilokani, L., Nagashima, S., Paupe, V. & Prudent, J. Mitochondrial dynamics: overview of molecular mechanisms. Essays Biochem 62, 341–360 (2018).
Palikaras, K., Lionaki, E. & Tavernarakis, N. Mechanisms of mitophagy in cellular homeostasis, physiology and pathology. Nat. Cell Biol. 20, 1013–1022 (2018).
Passarella, S., Atlante, A., Valenti, D. & de Bari, L. The role of mitochondrial transport in energy metabolism. Mitochondrion 2, 319–343 (2003).
Kuhlbrandt, W. Structure and function of mitochondrial membrane protein complexes. BMC Biol. 13, 89 (2015).
Heden, T. D., Neufer, P. D. & Funai, K. Looking beyond structure: membrane phospholipids of skeletal muscle mitochondria. Trends Endocrinol. Metab. 27, 553–562 (2016).
Bayrhuber, M. et al. Structure of the human voltage-dependent anion channel. Proc. Natl Acad. Sci. USA 105, 15370–15375 (2008).
Renault, T. T. & Chipuk, J. E. Death upon a kiss: mitochondrial outer membrane composition and organelle communication govern sensitivity to BAK/BAX-dependent apoptosis. Chem. Biol. 21, 114–123 (2014).
Gao, S. & Hu, J. Mitochondrial fusion: The machineries in and out. Trends Cell Biol. 31, 62–74 (2021).
Drago, I., Pizzo, P. & Pozzan, T. After half a century mitochondrial calcium in- and efflux machineries reveal themselves. EMBO J. 30, 4119–4125 (2011).
Zorov, D. B., Juhaszova, M. & Sollott, S. J. Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. Physiol. Rev. 94, 909–950 (2014).
Kinnally, K. W., Peixoto, P. M., Ryu, S. Y. & Dejean, L. M. Is mPTP the gatekeeper for necrosis, apoptosis, or both? Biochim. Biophys. Acta 1813, 616–622 (2011).
Habich, M., Salscheider, S. L. & Riemer, J. Cysteine residues in mitochondrial intermembrane space proteins: more than just import. Br. J. Pharmacol. 176, 514–531 (2019).
Dickson-Murray, E., Nedara, K., Modjtahedi, N. & Tokatlidis, K. The Mia40/CHCHD4 oxidative folding system: redox regulation and signaling in the mitochondrial intermembrane space. Antioxid. (Basel) 10, 592 (2021).
Munoz-Pinedo, C. et al. Different mitochondrial intermembrane space proteins are released during apoptosis in a manner that is coordinately initiated but can vary in duration. Proc. Natl Acad. Sci. USA 103, 11573–11578 (2006).
Edwards, R., Eaglesfield, R. & Tokatlidis, K. The mitochondrial intermembrane space: the most constricted mitochondrial sub-compartment with the largest variety of protein import pathways. Open Biol. 11, 210002 (2021).
Guo, R., Gu, J., Zong, S., Wu, M. & Yang, M. Structure and mechanism of mitochondrial electron transport chain. Biomed. J. 41, 9–20 (2018).
Quesnay, J. E. N. et al. Insights on the quest for the structure-function relationship of the mitochondrial pyruvate carrier. Biol. (Basel) 9, 407 (2020).
Ruprecht, J. J. et al. The Molecular mechanism of transport by the mitochondrial ADP/ATP carrier. Cell 176, 435–447 e415 (2019).
Voos, W. & Rottgers, K. Molecular chaperones as essential mediators of mitochondrial biogenesis. Biochim. Biophys. Acta 1592, 51–62 (2002).
Al Ojaimi, M., Salah, A. & El-Hattab, A. W. Mitochondrial fission and fusion: Molecular mechanisms, biological functions, and related disorders. Membr. (Basel) 12, 893 (2022).
Otera, H., Ishihara, N. & Mihara, K. New insights into the function and regulation of mitochondrial fission. Biochim. Biophys. Acta 1833, 1256–1268 (2013).
Fonseca, T. B., Sanchez-Guerrero, A., Milosevic, I. & Raimundo, N. Mitochondrial fission requires DRP1 but not dynamins. Nature 570, E34–E42 (2019).
Chang, C. R. & Blackstone, C. Dynamic regulation of mitochondrial fission through modification of the dynamin-related protein Drp1. Ann. Ny. Acad. Sci. 1201, 34–39 (2010).
Adaniya, S. M., J, O. U., Cypress, M. W., Kusakari, Y. & Jhun, B. S. Posttranslational modifications of mitochondrial fission and fusion proteins in cardiac physiology and pathophysiology. Am. J. Physiol. Cell Physiol. 316, C583–C604 (2019).
Yu, T., Jhun, B. S. & Yoon, Y. High-glucose stimulation increases reactive oxygen species production through the calcium and mitogen-activated protein kinase-mediated activation of mitochondrial fission. Antioxid. Redox Signal. 14, 425–437 (2011).
Figueroa-Romero, C. et al. SUMOylation of the mitochondrial fission protein Drp1 occurs at multiple nonconsensus sites within the B domain and is linked to its activity cycle. FASEB J. 23, 3917–3927 (2009).
Zaja, I. et al. Cdk1, PKCdelta and calcineurin-mediated Drp1 pathway contributes to mitochondrial fission-induced cardiomyocyte death. Biochem. Biophys. Res. Commun. 453, 710–721 (2014).
Cribbs, J. T. & Strack, S. Reversible phosphorylation of Drp1 by cyclic AMP-dependent protein kinase and calcineurin regulates mitochondrial fission and cell death. EMBO Rep. 8, 939–944 (2007).
Xu, S. et al. CaMKII induces permeability transition through Drp1 phosphorylation during chronic beta-AR stimulation. Nat. Commun. 7, 13189 (2016).
Guo, C. et al. SENP3-mediated deSUMOylation of dynamin-related protein 1 promotes cell death following ischaemia. EMBO J. 32, 1514–1528 (2013).
Toyama, E. Q. et al. Metabolism. AMP-activated protein kinase mediates mitochondrial fission in response to energy stress. Science 351, 275–281 (2016).
Xu, S. et al. Mitochondrial E3 ubiquitin ligase MARCH5 controls mitochondrial fission and cell sensitivity to stress-induced apoptosis through regulation of MiD49 protein. Mol. Biol. Cell 27, 349–359 (2016).
Frohlich, C. et al. Structural insights into oligomerization and mitochondrial remodelling of dynamin 1-like protein. EMBO J. 32, 1280–1292 (2013).
Ducommun, S. et al. Motif affinity and mass spectrometry proteomic approach for the discovery of cellular AMPK targets: identification of mitochondrial fission factor as a new AMPK substrate. Cell. Signal. 27, 978–988 (2015).
Burte, F., Carelli, V., Chinnery, P. F. & Yu-Wai-Man, P. Disturbed mitochondrial dynamics and neurodegenerative disorders. Nat. Rev. Neurol. 11, 11–24 (2015).
Suen, D. F., Norris, K. L. & Youle, R. J. Mitochondrial dynamics and apoptosis. Genes Dev. 22, 1577–1590 (2008).
Wakabayashi, J. et al. The dynamin-related GTPase Drp1 is required for embryonic and brain development in mice. J. Cell Biol. 186, 805–816 (2009).
van der Bliek, A. M., Shen, Q. & Kawajiri, S. Mechanisms of mitochondrial fission and fusion. Cold Spring Harb. Perspect. Biol. 5, a011072 (2013).
Chan, D. C. Mitochondrial fusion and fission in mammals. Annu Rev. Cell Dev. Biol. 22, 79–99 (2006).
Gao, Z. et al. Mitochondrial dynamics controls anti-tumour innate immunity by regulating CHIP-IRF1 axis stability. Nat. Commun. 8, 1805 (2017).
Pyakurel, A., Savoia, C., Hess, D. & Scorrano, L. Extracellular regulated kinase phosphorylates mitofusin 1 to control mitochondrial morphology and apoptosis. Mol. Cell 58, 244–254 (2015).
Chen, H. et al. Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development. J. Cell Biol. 160, 189–200 (2003).
Lee, J. Y. et al. MFN1 deacetylation activates adaptive mitochondrial fusion and protects metabolically challenged mitochondria. J. Cell Sci. 127, 4954–4963 (2014).
McLelland, G. L. & Fon, E. A. MFN2 retrotranslocation boosts mitophagy by uncoupling mitochondria from the ER. Autophagy 14, 1658–1660 (2018).
Leboucher, G. P. et al. Stress-induced phosphorylation and proteasomal degradation of mitofusin 2 facilitates mitochondrial fragmentation and apoptosis. Mol. Cell 47, 547–557 (2012).
Liesa, M. et al. Mitochondrial fusion is increased by the nuclear coactivator PGC-1beta. PLoS One3, e3613 (2008).
Li, J. et al. Mitofusin 1 is negatively regulated by microRNA 140 in cardiomyocyte apoptosis. Mol. Cell. Biol. 34, 1788–1799 (2014).
Ishihara, N., Fujita, Y., Oka, T. & Mihara, K. Regulation of mitochondrial morphology through proteolytic cleavage of OPA1. EMBO J. 25, 2966–2977 (2006).
Anand, R. et al. The i-AAA protease YME1L and OMA1 cleave OPA1 to balance mitochondrial fusion and fission. J. Cell Biol. 204, 919–929 (2014).
Cogliati, S. et al. Mitochondrial cristae shape determines respiratory chain supercomplexes assembly and respiratory efficiency. Cell 155, 160–171 (2013).
Davies, V. J. et al. Opa1 deficiency in a mouse model of autosomal dominant optic atrophy impairs mitochondrial morphology, optic nerve structure and visual function. Hum. Mol. Genet. 16, 1307–1318 (2007).
Ranieri, M. et al. Optic atrophy plus phenotype due to mutations in the OPA1 gene: two more Italian families. J. Neurol. Sci. 315, 146–149 (2012).
Lazarou, M. et al. The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy. Nature 524, 309–314 (2015).
Georgakopoulos, N. D., Wells, G. & Campanella, M. The pharmacological regulation of cellular mitophagy. Nat. Chem. Biol. 13, 136–146 (2017).
Misgeld, T. & Schwarz, T. L. Mitostasis in neurons: maintaining mitochondria in an extended cellular architecture. Neuron 96, 651–666 (2017).
Morin, M., Moindjie, H. & Nahmias, C. [Mitochondrial transport: How does it impact cancer?]. Med. Sci. (Paris) 38, 585–593 (2022).
van Spronsen, M. et al. TRAK/Milton motor-adaptor proteins steer mitochondrial trafficking to axons and dendrites. Neuron 77, 485–502 (2013).
Bocanegra, J. L. et al. The MyMOMA domain of MYO19 encodes for distinct Miro-dependent and Miro-independent mechanisms of interaction with mitochondrial membranes. Cytoskeleton (Hoboken) 77, 149–166 (2020).
Molina, A. J. et al. Mitochondrial networking protects beta-cells from nutrient-induced apoptosis. Diabetes 58, 2303–2315 (2009).
Rambold, A. S., Kostelecky, B., Elia, N. & Lippincott-Schwartz, J. Tubular network formation protects mitochondria from autophagosomal degradation during nutrient starvation. Proc. Natl Acad. Sci. USA 108, 10190–10195 (2011).
Chang, C. R. & Blackstone, C. Cyclic AMP-dependent protein kinase phosphorylation of Drp1 regulates its GTPase activity and mitochondrial morphology. J. Biol. Chem. 282, 21583–21587 (2007).
Nasrallah, C. M. & Horvath, T. L. Mitochondrial dynamics in the central regulation of metabolism. Nat. Rev. Endocrinol. 10, 650–658 (2014).
Wai, T. & Langer, T. Mitochondrial dynamics and metabolic regulation. Trends Endocrinol. Metab. 27, 105–117 (2016).
Jha, A. K. et al. Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization. Immunity 42, 419–430 (2015).
Buck, M. D. et al. Mitochondrial dynamics controls T cell fate through metabolic programming. Cell 166, 63–76 (2016).
Cunniff, B., McKenzie, A. J., Heintz, N. H. & Howe, A. K. AMPK activity regulates trafficking of mitochondria to the leading edge during cell migration and matrix invasion. Mol. Biol. Cell 27, 2662–2674 (2016).
Paupe, V. & Prudent, J. New insights into the role of mitochondrial calcium homeostasis in cell migration. Biochem. Biophys. Res. Commun. 500, 75–86 (2018).
Zhang, L., Zhang, Y., Chang, X. & Zhang, X. Imbalance in mitochondrial dynamics induced by low PGC-1alpha expression contributes to hepatocyte EMT and liver fibrosis. Cell Death Dis. 11, 226 (2020).
Zhao, J. et al. Mitochondrial dynamics regulates migration and invasion of breast cancer cells. Oncogene 32, 4814–4824 (2013).
Klein, L., Kyewski, B., Allen, P. M. & Hogquist, K. A. Positive and negative selection of the T cell repertoire: what thymocytes see (and don’t see). Nat. Rev. Immunol. 14, 377–391 (2014).
Campello, S. et al. Orchestration of lymphocyte chemotaxis by mitochondrial dynamics. J. Exp. Med. 203, 2879–2886 (2006).
Lamouille, S., Xu, J. & Derynck, R. Molecular mechanisms of epithelial-mesenchymal transition. Nat. Rev. Mol. Cell Biol. 15, 178–196 (2014).
Han, L. et al. Retrograde regulation of mitochondrial fission and epithelial to mesenchymal transition in hepatocellular carcinoma by GCN5L1. Oncogene 42, 1024–1037 (2023).
Seo, B. J., Yoon, S. H. & Do, J. T. Mitochondrial dynamics in stem cells and differentiation. Int. J. Mol. Sci. 19, 3893 (2018).
Hofmann, A. D. et al. OXPHOS supercomplexes as a hallmark of the mitochondrial phenotype of adipogenic differentiated human MSCs. PLoS One7, e35160 (2012).
Forni, M. F., Peloggia, J., Trudeau, K., Shirihai, O. & Kowaltowski, A. J. Murine mesenchymal stem cell commitment to differentiation is regulated by mitochondrial dynamics. Stem Cells 34, 743–755 (2016).
Zhang, Y., Marsboom, G., Toth, P. T. & Rehman, J. Mitochondrial respiration regulates adipogenic differentiation of human mesenchymal stem cells. PLoS ONE 8, e77077 (2013).
Jeong, S., Seong, J. H., Kang, J. H., Lee, D. S. & Yim, M. Dynamin-related protein 1 positively regulates osteoclast differentiation and bone loss. FEBS Lett. 595, 58–67 (2021).
Park, B. V. & Pan, F. Metabolic regulation of T cell differentiation and function. Mol. Immunol. 68, 497–506 (2015).
Rambold, A. S. & Pearce, E. L. Mitochondrial dynamics at the interface of immune cell metabolism and function. Trends Immunol. 39, 6–18 (2018).
Pangou, E. & Sumara, I. The multifaceted regulation of mitochondrial dynamics during mitosis. Front. Cell Dev. Biol. 9, 767221 (2021).
Horbay, R. & Bilyy, R. Mitochondrial dynamics during cell cycling. Apoptosis 21, 1327–1335 (2016).
Salazar-Roa, M. & Malumbres, M. Fueling the cell division cycle. Trends Cell Biol. 27, 69–81 (2017).
Qian, W. et al. Mitochondrial hyperfusion induced by loss of the fission protein Drp1 causes ATM-dependent G2/M arrest and aneuploidy through DNA replication stress. J. Cell. Sci. 125, 5745–5757 (2012).
Taguchi, N., Ishihara, N., Jofuku, A., Oka, T. & Mihara, K. Mitotic phosphorylation of dynamin-related GTPase Drp1 participates in mitochondrial fission. J. Biol. Chem. 282, 11521–11529 (2007).
Kashatus, D. F. et al. RALA and RALBP1 regulate mitochondrial fission at mitosis. Nat. Cell Biol. 13, 1108–1115 (2011).
Ben-Porath, I. & Weinberg, R. A. When cells get stressed: an integrative view of cellular senescence. J. Clin. Invest. 113, 8–13 (2004).
Hwang, E. S., Yoon, G. & Kang, H. T. A comparative analysis of the cell biology of senescence and aging. Cell. Mol. Life Sci. 66, 2503–2524 (2009).
Mai, S., Klinkenberg, M., Auburger, G., Bereiter-Hahn, J. & Jendrach, M. Decreased expression of Drp1 and Fis1 mediates mitochondrial elongation in senescent cells and enhances resistance to oxidative stress through PINK1. J. Cell. Sci. 123, 917–926 (2010).
Kosyakovsky, J., Fine, J. M., Frey, W. H. 2nd & Hanson, L. R. Mechanisms of Intranasal deferoxamine in neurodegenerative and neurovascular disease. Pharm. (Basel) 14, 95 (2021).
Yoon, Y. S. et al. Formation of elongated giant mitochondria in DFO-induced cellular senescence: involvement of enhanced fusion process through modulation of Fis1. J. Cell. Physiol. 209, 468–480 (2006).
Kim, Y. Y. et al. p53 regulates mitochondrial dynamics by inhibiting Drp1 translocation into mitochondria during cellular senescence. FASEB J. 34, 2451–2464 (2020).
Wang, Z., Jiang, H., Chen, S., Du, F. & Wang, X. The mitochondrial phosphatase PGAM5 functions at the convergence point of multiple necrotic death pathways. Cell 148, 228–243 (2012).
Yu, B. et al. Mitochondrial phosphatase PGAM5 modulates cellular senescence by regulating mitochondrial dynamics. Nat. Commun. 11, 2549 (2020).
Adams, J. M. & Cory, S. Bcl-2-regulated apoptosis: mechanism and therapeutic potential. Curr. Opin. Immunol. 19, 488–496 (2007).
Taylor, R. C., Cullen, S. P. & Martin, S. J. Apoptosis: controlled demolition at the cellular level. Nat. Rev. Mol. Cell Biol. 9, 231–241 (2008).
Schinzel, A., Kaufmann, T. & Borner, C. Bcl-2 family members: integrators of survival and death signals in physiology and pathology [corrected]. Biochim. Biophys. Acta 1644, 95–105 (2004).
Martinou, J. C. & Youle, R. J. Mitochondria in apoptosis: Bcl-2 family members and mitochondrial dynamics. Dev. Cell 21, 92–101 (2011).
Zamzami, N. & Kroemer, G. The mitochondrion in apoptosis: how Pandora’s box opens. Nat. Rev. Mol. Cell Biol. 2, 67–71 (2001).
Sheridan, C. & Martin, S. J. Mitochondrial fission/fusion dynamics and apoptosis. Mitochondrion 10, 640–648 (2010).
Karbowski, M. et al. Spatial and temporal association of Bax with mitochondrial fission sites, Drp1, and Mfn2 during apoptosis. J. Cell Biol. 159, 931–938 (2002).
Estaquier, J. & Arnoult, D. Inhibiting Drp1-mediated mitochondrial fission selectively prevents the release of cytochrome c during apoptosis. Cell Death Differ. 14, 1086–1094 (2007).
Arnoult, D. et al. Bax/Bak-dependent release of DDP/TIMM8a promotes Drp1-mediated mitochondrial fission and mitoptosis during programmed cell death. Curr. Biol. 15, 2112–2118 (2005).
Karbowski, M. et al. Quantitation of mitochondrial dynamics by photolabeling of individual organelles shows that mitochondrial fusion is blocked during the Bax activation phase of apoptosis. J. Cell Biol. 164, 493–499 (2004).
Sheridan, C., Delivani, P., Cullen, S. P. & Martin, S. J. Bax- or Bak-induced mitochondrial fission can be uncoupled from cytochrome C release. Mol. Cell 31, 570–585 (2008).
Yamaguchi, R. et al. Opa1-mediated cristae opening is Bax/Bak and BH3 dependent, required for apoptosis, and independent of Bak oligomerization. Mol. Cell 31, 557–569 (2008).
Olichon, A. et al. Loss of OPA1 perturbates the mitochondrial inner membrane structure and integrity, leading to cytochrome c release and apoptosis. J. Biol. Chem. 278, 7743–7746 (2003).
Tanaka, T. et al. Mitochondrial dynamics in exercise physiology. Pflug. Arch. 472, 137–153 (2020).
Holloszy, J. O. Biochemical adaptations in muscle. Effects of exercise on mitochondrial oxygen uptake and respiratory enzyme activity in skeletal muscle. J. Biol. Chem. 242, 2278–2282 (1967).
Scalzo, R. L. et al. Greater muscle protein synthesis and mitochondrial biogenesis in males compared with females during sprint interval training. FASEB J. 28, 2705–2714 (2014).
Jager, S., Handschin, C., St-Pierre, J. & Spiegelman, B. M. AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha. Proc. Natl Acad. Sci. USA 104, 12017–12022 (2007).
Vega, R. B., Huss, J. M. & Kelly, D. P. The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes. Mol. Cell. Biol. 20, 1868–1876 (2000).
Akimoto, T., Li, P. & Yan, Z. Functional interaction of regulatory factors with the Pgc-1alpha promoter in response to exercise by in vivo imaging. Am. J. Physiol. Cell Physiol. 295, C288–C292 (2008).
Jin, S. M. et al. Mitochondrial membrane potential regulates PINK1 import and proteolytic destabilization by PARL. J. Cell Biol. 191, 933–942 (2010).
Lira, V. A. et al. Autophagy is required for exercise training-induced skeletal muscle adaptation and improvement of physical performance. FASEB J. 27, 4184–4193 (2013).
Hoffman, N. J. et al. Global phosphoproteomic analysis of human skeletal muscle reveals a network of exercise-regulated kinases and AMPK substrates. Cell Metab. 22, 922–935 (2015).
Merrill, R. A. & Strack, S. Mitochondria: a kinase anchoring protein 1, a signaling platform for mitochondrial form and function. Int. J. Biochem. Cell Biol. 48, 92–96 (2014).
Kitaoka, Y., Ogasawara, R., Tamura, Y., Fujita, S. & Hatta, H. Effect of electrical stimulation-induced resistance exercise on mitochondrial fission and fusion proteins in rat skeletal muscle. Appl. Physiol. Nutr. Metab. 40, 1137–1142 (2015).
Kruse, R. et al. Intact initiation of autophagy and mitochondrial fission by acute exercise in skeletal muscle of patients with Type 2 diabetes. Clin. Sci. (Lond.) 131, 37–47 (2017).
Iqbal, S. & Hood, D. A. Oxidative stress-induced mitochondrial fragmentation and movement in skeletal muscle myoblasts. Am. J. Physiol. Cell Physiol. 306, C1176–C1183 (2014).
Cartoni, R. et al. Mitofusins 1/2 and ERRalpha expression are increased in human skeletal muscle after physical exercise. J. Physiol. 567, 349–358 (2005).
Lopez-Otin, C., Blasco, M. A., Partridge, L., Serrano, M. & Kroemer, G. The hallmarks of aging. Cell 153, 1194–1217 (2013).
Trifunovic, A. et al. Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature 429, 417–423 (2004).
Kujoth, G. C. et al. Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science 309, 481–484 (2005).
Palikaras, K., Lionaki, E. & Tavernarakis, N. Coordination of mitophagy and mitochondrial biogenesis during ageing in C. elegans. Nature 521, 525–528 (2015).
Schiavi, A. et al. Iron-starvation-induced mitophagy mediates lifespan extension upon mitochondrial stress in C. elegans. Curr. Biol. 25, 1810–1822 (2015).
Ryu, D. et al. Urolithin A induces mitophagy and prolongs lifespan in C. elegans and increases muscle function in rodents. Nat. Med. 22, 879–888 (2016).
Kageyama, Y. et al. Mitochondrial division ensures the survival of postmitotic neurons by suppressing oxidative damage. J. Cell Biol. 197, 535–551 (2012).
Rana, A. et al. Promoting Drp1-mediated mitochondrial fission in midlife prolongs healthy lifespan of Drosophila melanogaster. Nat. Commun. 8, 448 (2017).
Han, B. et al. Microbial genetic composition tunes host longevity. Cell 169, 1249–1262 e1213 (2017).
Scheckhuber, C. Q. et al. Reducing mitochondrial fission results in increased life span and fitness of two fungal ageing models. Nat. Cell Biol. 9, 99–105 (2007).
Jheng, H. F. et al. Mitochondrial fission contributes to mitochondrial dysfunction and insulin resistance in skeletal muscle. Mol. Cell. Biol. 32, 309–319 (2012).
Chaudhari, S. N. & Kipreos, E. T. Increased mitochondrial fusion allows the survival of older animals in diverse C. elegans longevity pathways. Nat. Commun. 8, 182 (2017).
Weir, H. J. et al. Dietary restriction and AMPK increase lifespan via mitochondrial network and peroxisome remodeling. Cell Metab. 26, 884–896 e885 (2017).
Zhang, Y. et al. Neuronal TORC1 modulates longevity via AMPK and cell nonautonomous regulation of mitochondrial dynamics in C. elegans. Elife 8, e49158 (2019).
Rho, J. M. How does the ketogenic diet induce anti-seizure effects? Neurosci. Lett. 637, 4–10 (2017).
Ruskin, D. N. et al. Ketogenic diet improves core symptoms of autism in BTBR mice. PLoS One 8, e65021 (2013).
Feinman, R. D. et al. Dietary carbohydrate restriction as the first approach in diabetes management: critical review and evidence base. Nutrition 31, 1–13 (2015).
Kossoff, E. H., Zupec-Kania, B. A. & Rho, J. M. Ketogenic diets: an update for child neurologists. J. Child. Neurol. 24, 979–988 (2009).
Newell, C. et al. Tissue specific impacts of a ketogenic diet on mitochondrial dynamics in the BTBR(T+tf/j) Mouse. Front. Physiol. 7, 654 (2016).
Guo, Y. et al. Ketogenic diet ameliorates cardiac dysfunction via balancing mitochondrial dynamics and inhibiting apoptosis in Type 2 diabetic mice. Aging Dis. 11, 229–240 (2020).
Ahn, Y. et al. Aberrant mitochondrial morphology and function in the BTBR mouse model of autism is improved by 2 weeks of ketogenic diet. Int. J. Mol. Sci. 21, 3266 (2020).
Chen, L., Winger, A. J. & Knowlton, A. A. Mitochondrial dynamic changes in health and genetic diseases. Mol. Biol. Rep. 41, 7053–7062 (2014).
Morena, J., Gupta, A. & Hoyle, J. C. Charcot-Marie-Tooth: from molecules to therapy. Int. J. Mol. Sci. 20, 3419 (2019).
Saporta, A. S. et al. Charcot-Marie-Tooth disease subtypes and genetic testing strategies. Ann. Neurol. 69, 22–33 (2011).
Fridman, V. et al. CMT subtypes and disease burden in patients enrolled in the Inherited Neuropathies Consortium natural history study: a cross-sectional analysis. J. Neurol. Neurosurg. Psychiatry 86, 873–878 (2015).
Rudnik-Schoneborn, S. et al. Diagnostic algorithms in Charcot-Marie-Tooth neuropathies: experiences from a German genetic laboratory on the basis of 1206 index patients. Clin. Genet. 89, 34–43 (2016).
Takahashi, R., Ikeda, T., Hamaguchi, A., Iwasa, K. & Yamada, M. Coenzyme Q10 therapy in hereditary motor sensory neuropathy type VI with novel mitofusin 2 mutation. Intern. Med. 51, 791–793 (2012).
Rocha, A. G. et al. MFN2 agonists reverse mitochondrial defects in preclinical models of Charcot-Marie-Tooth disease type 2A. Science 360, 336–341 (2018).
Lenaers, G. et al. Dominant optic atrophy. Orphanet. J. Rare. Dis. 7, 46 (2012).
Juschke, C. et al. Autosomal dominant optic atrophy: A novel treatment for OPA1 splice defects using U1 snRNA adaption. Mol. Ther. Nucleic Acids 26, 1186–1197 (2021).
Cabreira, V. & Massano, J. [Parkinson’s disease: clinical review and update]. Acta Med. Port. 32, 661–670 (2019).
Mann, V. M. et al. Complex I, iron, and ferritin in Parkinson’s disease substantia nigra. Ann. Neurol. 36, 876–881 (1994).
Pozo Devoto, V. M. & Falzone, T. L. Mitochondrial dynamics in Parkinson’s disease: a role for alpha-synuclein? Dis. Model Mech. 10, 1075–1087 (2017).
Khacho, M. & Slack, R. S. Mitochondrial dynamics in the regulation of neurogenesis: From development to the adult brain. Dev. Dyn. 247, 47–53 (2018).
Chen, H. & Chan, D. C. Mitochondrial dynamics–fusion, fission, movement, and mitophagy–in neurodegenerative diseases. Hum. Mol. Genet. 18, R169–R176 (2009).
Li, Z., Okamoto, K., Hayashi, Y. & Sheng, M. The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses. Cell 119, 873–887 (2004).
Verstreken, P. et al. Synaptic mitochondria are critical for mobilization of reserve pool vesicles at Drosophila neuromuscular junctions. Neuron 47, 365–378 (2005).
Lim, K. L., Ng, X. H., Grace, L. G. & Yao, T. P. Mitochondrial dynamics and Parkinson’s disease: focus on parkin. Antioxid. Redox Signal. 16, 935–949 (2012).
Pickrell, A. M. & Youle, R. J. The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson’s disease. Neuron 85, 257–273 (2015).
Rana, A., Rera, M. & Walker, D. W. Parkin overexpression during aging reduces proteotoxicity, alters mitochondrial dynamics, and extends lifespan. Proc. Natl Acad. Sci. USA 110, 8638–8643 (2013).
Krzystek, T. J. et al. Differential mitochondrial roles for alpha-synuclein in DRP1-dependent fission and PINK1/Parkin-mediated oxidation. Cell Death Dis. 12, 796 (2021).
Castellani, R. J., Rolston, R. K. & Smith, M. A. Alzheimer disease. Dis. Mon. 56, 484–546 (2010).
Blass, J. P. The mitochondrial spiral. An adequate cause of dementia in the Alzheimer’s syndrome. Ann. Ny. Acad. Sci. 924, 170–183 (2000).
Reddy, P. H. & Beal, M. F. Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer’s disease. Trends Mol. Med. 14, 45–53 (2008).
Keller, J. N., Guo, Q., Holtsberg, F. W., Bruce-Keller, A. J. & Mattson, M. P. Increased sensitivity to mitochondrial toxin-induced apoptosis in neural cells expressing mutant presenilin-1 is linked to perturbed calcium homeostasis and enhanced oxyradical production. J. Neurosci. 18, 4439–4450 (1998).
Coskun, P. E., Beal, M. F. & Wallace, D. C. Alzheimer’s brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication. Proc. Natl Acad. Sci. USA 101, 10726–10731 (2004).
Hirai, K. et al. Mitochondrial abnormalities in Alzheimer’s disease. J. Neurosci. 21, 3017–3023 (2001).
Wang, X. et al. Impaired balance of mitochondrial fission and fusion in Alzheimer’s disease. J. Neurosci. 29, 9090–9103 (2009).
Silva-Alvarez, C., Arrazola, M. S., Godoy, J. A., Ordenes, D. & Inestrosa, N. C. Canonical Wnt signaling protects hippocampal neurons from Abeta oligomers: role of non-canonical Wnt-5a/Ca(2+) in mitochondrial dynamics. Front. Cell. Neurosci. 7, 97 (2013).
Wang, C. et al. AdipoRon mitigates tau pathology and restores mitochondrial dynamics via AMPK-related pathway in a mouse model of Alzheimer’s disease. Exp. Neurol. 363, 114355 (2023).
Cho, D. H. et al. S-nitrosylation of Drp1 mediates beta-amyloid-related mitochondrial fission and neuronal injury. Science 324, 102–105 (2009).
Bates, G. P. History of genetic disease: the molecular genetics of Huntington disease – a history. Nat. Rev. Genet. 6, 766–773 (2005).
Reddy, P. H. Increased mitochondrial fission and neuronal dysfunction in Huntington’s disease: implications for molecular inhibitors of excessive mitochondrial fission. Drug Discov. Today 19, 951–955 (2014).
Shirendeb, U. et al. Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington’s disease: implications for selective neuronal damage. Hum. Mol. Genet. 20, 1438–1455 (2011).
Shirendeb, U. P. et al. Mutant huntingtin’s interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington’s disease. Hum. Mol. Genet. 21, 406–420 (2012).
Song, W. et al. Mutant huntingtin binds the mitochondrial fission GTPase dynamin-related protein-1 and increases its enzymatic activity. Nat. Med. 17, 377–382 (2011).
Kim, J. et al. Mitochondrial loss, dysfunction and altered dynamics in Huntington’s disease. Hum. Mol. Genet. 19, 3919–3935 (2010).
Lin, H. Y. et al. The causal role of mitochondrial dynamics in regulating insulin resistance in diabetes: link through mitochondrial reactive oxygen species. Oxid. Med. Cell. Longev. 2018, 7514383 (2018).
Kolac, U. K., Donmez Yalcin, G. & Yalcin, A. Chemical inhibition of mitochondrial fission improves insulin signaling and subdues hyperglycemia induced stress in placental trophoblast cells. Mol. Biol. Rep. 50, 493–506 (2023).
Dong, Y. et al. Role of endoplasmic reticulum stress signalling in diabetic endothelial dysfunction and atherosclerosis. Diab. Vasc. Dis. Res. 14, 14–23 (2017).
Peng, L. et al. Dynamin-related protein 1 is implicated in endoplasmic reticulum stress-induced pancreatic beta-cell apoptosis. Int. J. Mol. Med. 28, 161–169 (2011).
Liu, J. et al. Rhein protects pancreatic beta-cells from dynamin-related protein-1-mediated mitochondrial fission and cell apoptosis under hyperglycemia. Diabetes 62, 3927–3935 (2013).
Sanyal, A. J. et al. Endpoints and clinical trial design for nonalcoholic steatohepatitis. Hepatology 54, 344–353 (2011).
Tarantino, G. & Finelli, C. What about non-alcoholic fatty liver disease as a new criterion to define metabolic syndrome? World J. Gastroenterol. 19, 3375–3384 (2013).
Romeo, S. et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat. Genet. 40, 1461–1465 (2008).
Dongiovanni, P. et al. Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease. Hepatology 61, 506–514 (2015).
Li, Z., Berk, M., McIntyre, T. M., Gores, G. J. & Feldstein, A. E. The lysosomal-mitochondrial axis in free fatty acid-induced hepatic lipotoxicity. Hepatology 47, 1495–1503 (2008).
Galloway, C. A., Lee, H., Brookes, P. S. & Yoon, Y. Decreasing mitochondrial fission alleviates hepatic steatosis in a murine model of nonalcoholic fatty liver disease. Am. J. Physiol. Gastrointest. Liver Physiol. 307, G632–G641 (2014).
Gong, F., Gao, L. & Ding, T. IDH2 protects against nonalcoholic steatohepatitis by alleviating dyslipidemia regulated by oxidative stress. Biochem. Biophys. Res. Commun. 514, 593–600 (2019).
Du, J. et al. Pro-inflammatory CXCR3 impairs mitochondrial function in experimental non-alcoholic steatohepatitis. Theranostics 7, 4192–4203 (2017).
Zhang, L., Seitz, L. C., Abramczyk, A. M. & Chan, C. Synergistic effect of cAMP and palmitate in promoting altered mitochondrial function and cell death in HepG2 cells. Exp. Cell. Res. 316, 716–727 (2010).
Bach, D. et al. Mitofusin-2 determines mitochondrial network architecture and mitochondrial metabolism. A novel regulatory mechanism altered in obesity. J. Biol. Chem. 278, 17190–17197 (2003).
Galloway, C. A. et al. Transgenic control of mitochondrial fission induces mitochondrial uncoupling and relieves diabetic oxidative stress. Diabetes 61, 2093–2104 (2012).
Yellon, D. M. & Hausenloy, D. J. Myocardial reperfusion injury. N. Engl. J. Med. 357, 1121–1135 (2007).
Heusch, G. Myocardial ischaemia-reperfusion injury and cardioprotection in perspective. Nat. Rev. Cardiol. 17, 773–789 (2020).
Hausenloy, D. J. & Yellon, D. M. Myocardial ischemia-reperfusion injury: a neglected therapeutic target. J. Clin. Invest. 123, 92–100 (2013).
Plotnikov, E. Y. et al. Interrelations of mitochondrial fragmentation and cell death under ischemia/reoxygenation and UV-irradiation: protective effects of SkQ1, lithium ions and insulin. FEBS Lett. 582, 3117–3124 (2008).
Hom, J. R., Gewandter, J. S., Michael, L., Sheu, S. S. & Yoon, Y. Thapsigargin induces biphasic fragmentation of mitochondria through calcium-mediated mitochondrial fission and apoptosis. J. Cell. Physiol. 212, 498–508 (2007).
Maneechote, C. et al. Pharmacological inhibition of mitochondrial fission attenuates cardiac ischemia-reperfusion injury in pre-diabetic rats. Biochem. Pharmacol. 182, 114295 (2020).
Jin, Q. et al. DUSP1 alleviates cardiac ischemia/reperfusion injury by suppressing the Mff-required mitochondrial fission and Bnip3-related mitophagy via the JNK pathways. Redox Biol. 14, 576–587 (2018).
Guan, L. et al. MCU Up-regulation contributes to myocardial ischemia-reperfusion Injury through calpain/OPA-1-mediated mitochondrial fusion/mitophagy Inhibition. J. Cell. Mol. Med. 23, 7830–7843 (2019).
Zhang, Y. et al. Melatonin attenuates myocardial ischemia-reperfusion injury via improving mitochondrial fusion/mitophagy and activating the AMPK-OPA1 signaling pathways. J. Pineal Res. 66, e12542 (2019).
Alpert, C. M., Smith, M. A., Hummel, S. L. & Hummel, E. K. Symptom burden in heart failure: assessment, impact on outcomes, and management. Heart Fail. Rev. 22, 25–39 (2017).
Chen, Y. R. & Zweier, J. L. Cardiac mitochondria and reactive oxygen species generation. Circ. Res. 114, 524–537 (2014).
Chen, L., Gong, Q., Stice, J. P. & Knowlton, A. A. Mitochondrial OPA1, apoptosis, and heart failure. Cardiovasc. Res. 84, 91–99 (2009).
Wai, T. et al. Imbalanced OPA1 processing and mitochondrial fragmentation cause heart failure in mice. Science 350, aad0116 (2015).
Hu, J. et al. Omentin1 ameliorates myocardial ischemia-induced heart failure via SIRT3/FOXO3a-dependent mitochondrial dynamical homeostasis and mitophagy. J. Transl. Med. 20, 447 (2022).
Riba, A. et al. Doxycycline protects against ROS-induced mitochondrial fragmentation and ISO-induced heart failure. PLoS One 12, e0175195 (2017).
Chen, Y., Liu, Y. & Dorn, G. W. Mitochondrial fusion is essential for organelle function and cardiac homeostasis. Circ. Res. 109, 1327–1331 (2011). 2nd.
Dorn, G. W. 2nd et al. MARF and Opa1 control mitochondrial and cardiac function in Drosophila. Circ. Res. 108, 12–17 (2011).
Bugger, H. & Abel, E. D. Molecular mechanisms of diabetic cardiomyopathy. Diabetologia 57, 660–671 (2014).
Hu, L. et al. Targeting mitochondrial dynamics by regulating Mfn2 for therapeutic intervention in diabetic cardiomyopathy. Theranostics 9, 3687–3706 (2019).
Liu, C. et al. Paeonol promotes Opa1-mediated mitochondrial fusion via activating the CK2alpha-Stat3 pathway in diabetic cardiomyopathy. Redox Biol. 46, 102098 (2021).
Chen, H. et al. Titration of mitochondrial fusion rescues Mff-deficient cardiomyopathy. J. Cell Biol. 211, 795–805 (2015).
Wallace, D. C. Mitochondria and cancer. Nat. Rev. Cancer 12, 685–698 (2012).
Breda, C. N. S., Davanzo, G. G., Basso, P. J., Saraiva Camara, N. O. & Moraes-Vieira, P. M. M. Mitochondria as central hub of the immune system. Redox Biol. 26, 101255 (2019).
Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646–674 (2011).
Arismendi-Morillo, G. Electron microscopy morphology of the mitochondrial network in human cancer. Int. J. Biochem. Cell Biol. 41, 2062–2068 (2009).
Rehman, J. et al. Inhibition of mitochondrial fission prevents cell cycle progression in lung cancer. FASEB J. 26, 2175–2186 (2012).
Li, S. et al. FUNDC2 promotes liver tumorigenesis by inhibiting MFN1-mediated mitochondrial fusion. Nat. Commun. 13, 3486 (2022).
Zhang, G. E. et al. Anti-tumor effects of Mfn2 in gastric cancer. Int. J. Mol. Sci. 14, 13005–13021 (2013).
Kashatus, J. A. et al. Erk2 phosphorylation of Drp1 promotes mitochondrial fission and MAPK-driven tumor growth. Mol. Cell 57, 537–551 (2015).
Tian, G. A. et al. CCBE1 promotes mitochondrial fusion by inhibiting the TGFbeta-DRP1 axis to prevent the progression of hepatocellular carcinoma. Matrix Biol. 117, 31–45 (2023).
Liu, X. et al. Mfn2 inhibits proliferation and cell-cycle in Hela cells via Ras-NF-kappaB signal pathway. Cancer Cell Int 19, 197 (2019).
Chen, P. et al. Rab32 promotes glioblastoma migration and invasion via regulation of ERK/Drp1-mediated mitochondrial fission. Cell Death Dis. 14, 198 (2023).
Ferreira-da-Silva, A. et al. Mitochondrial dynamics protein Drp1 is overexpressed in oncocytic thyroid tumors and regulates cancer cell migration. PLoS One 10, e0122308 (2015).
Zhang, Z. et al. MFN1-dependent alteration of mitochondrial dynamics drives hepatocellular carcinoma metastasis by glucose metabolic reprogramming. Br. J. Cancer 122, 209–220 (2020).
Sun, X. et al. Mitochondrial fission promotes cell migration by Ca2+ /CaMKII/ERK/FAK pathway in hepatocellular carcinoma. Liver Int 38, 1263–1272 (2018).
Che, T. F. et al. Mitochondrial translocation of EGFR regulates mitochondria dynamics and promotes metastasis in NSCLC. Oncotarget 6, 37349–37366 (2015).
Fu, L. et al. SIRT4 inhibits malignancy progression of NSCLCs, through mitochondrial dynamics mediated by the ERK-Drp1 pathway. Oncogene 36, 2724–2736 (2017).
Vasan, N., Baselga, J. & Hyman, D. M. A view on drug resistance in cancer. Nature 575, 299–309 (2019).
Fu, Y. et al. Targeting mitochondrial dynamics by AZD5363 in triple-negative breast cancer MDA-MB-231 cell-derived spheres. Naunyn-Schmiedebergs Arch. Pharmacol. https://doi.org/10.1007/s00210-023-02477-7 (2023).
Romani, P. et al. Mitochondrial fission links ECM mechanotransduction to metabolic redox homeostasis and metastatic chemotherapy resistance. Nat. Cell Biol. 24, 168–180 (2022).
Noguchi, M. et al. Inhibition of the mitochondria-shaping protein Opa1 restores sensitivity to Gefitinib in a lung adenocarcinoma resistant cell line. Cell Death Dis. 14, 241 (2023).
Li, X. et al. Mitochondrial fission factor promotes cisplatin resistance in hepatocellular carcinoma. Acta Biochim. Biophys. Sin. (Shanghai) 54, 301–310 (2022).
Qian, W. et al. Novel combination of mitochondrial division inhibitor 1 (mdivi-1) and platinum agents produces synergistic pro-apoptotic effect in drug resistant tumor cells. Oncotarget 5, 4180–4194 (2014).
Zou, G. P. et al. Mitochondrial dynamics mediated by DRP1 and MFN2 contributes to cisplatin chemoresistance in human ovarian cancer SKOV3 cells. J. Cancer 12, 7358–7373 (2021).
Decker, C. W. et al. Mitofusin-2 mediates doxorubicin sensitivity and acute resistance in Jurkat leukemia cells. Biochem. Biophys. Rep. 24, 100824 (2020).
Cai, J. et al. ERK/Drp1-dependent mitochondrial fission is involved in the MSC-induced drug resistance of T-cell acute lymphoblastic leukemia cells. Cell Death Dis. 7, e2459 (2016).
Huang, C. Y. et al. HMGB1 promotes ERK-mediated mitochondrial Drp1 phosphorylation for chemoresistance through RAGE in colorectal cancer. Cell Death Dis. 9, 1004 (2018).
Mulder, W. J. M. & Gnjatic, S. Cancer immunotherapy: from local to global. Nat. Nanotechnol. 12, 840–841 (2017).
Bernard, N. J. Immunotherapy response. Nat. Immunol. 24, 2 (2023).
Chen, H. et al. Mitochondrial fusion is required for mtDNA stability in skeletal muscle and tolerance of mtDNA mutations. Cell 141, 280–289 (2010).
Bao, D. et al. Mitochondrial fission-induced mtDNA stress promotes tumor-associated macrophage infiltration and HCC progression. Oncogene 38, 5007–5020 (2019).
Simula, L. et al. PD-1-induced T cell exhaustion is controlled by a Drp1-dependent mechanism. Mol. Oncol. 16, 188–205 (2022).
Liu, Y. N. et al. Hypoxia induces mitochondrial defect that promotes T cell exhaustion in tumor microenvironment through MYC-regulated pathways. Front. Immunol. 11, 1906 (2020).
Mantovani, A., Marchesi, F., Malesci, A., Laghi, L. & Allavena, P. Tumour-associated macrophages as treatment targets in oncology. Nat. Rev. Clin. Oncol. 14, 399–416 (2017).
Zheng, X. et al. Mitochondrial fragmentation limits NK cell-based tumor immunosurveillance. Nat. Immunol. 20, 1656–1667 (2019).
Park, J. D. et al. ELK3 modulates the antitumor efficacy of natural killer cells against triple negative breast cancer by regulating mitochondrial dynamics. J. Immunother. Cancer 10, e004825 (2022).
Zhao, H. & Li, Y. Cancer metabolism and intervention therapy. Mol. Biomed. 2, 5 (2021).
Martinez-Outschoorn, U. E. et al. Tumor cells induce the cancer associated fibroblast phenotype via caveolin-1 degradation: implications for breast cancer and DCIS therapy with autophagy inhibitors. Cell Cycle 9, 2423–2433 (2010).
Guido, C. et al. Mitochondrial fission induces glycolytic reprogramming in cancer-associated myofibroblasts, driving stromal lactate production, and early tumor growth. Oncotarget 3, 798–810 (2012).
Blagih, J., Hennequart, M. & Zani, F. Tissue nutrient environments and their effect on regulatory T cell biology. Front. Immunol. 12, 637960 (2021).
Pacella, I. & Piconese, S. Immunometabolic checkpoints of Treg dynamics: adaptation to microenvironmental opportunities and challenges. Front. Immunol. 10, 1889 (2019).
Weinberg, S. E. et al. Mitochondrial complex III is essential for suppressive function of regulatory T cells. Nature 565, 495–499 (2019).
Tauriello, D. V. F., Sancho, E. & Batlle, E. Overcoming TGFbeta-mediated immune evasion in cancer. Nat. Rev. Cancer 22, 25–44 (2022).
Fang, Y. et al. Mitochondrial fusion induced by transforming growth factor-beta1 serves as a switch that governs the metabolic reprogramming during differentiation of regulatory T cells. Redox Biol. 62, 102709 (2023).
Dabrowska, A. et al. PGC-1alpha controls mitochondrial biogenesis and dynamics in lead-induced neurotoxicity. Aging 7, 629–647 (2015).
Beier, U. H. et al. Essential role of mitochondrial energy metabolism in Foxp3+ T-regulatory cell function and allograft survival. FASEB J. 29, 2315–2326 (2015).
Cassidy-Stone, A. et al. Chemical inhibition of the mitochondrial division dynamin reveals its role in Bax/Bak-dependent mitochondrial outer membrane permeabilization. Dev. Cell 14, 193–204 (2008).
Qi, X., Qvit, N., Su, Y. C. & Mochly-Rosen, D. A novel Drp1 inhibitor diminishes aberrant mitochondrial fission and neurotoxicity. J. Cell Sci. 126, 789–802 (2013).
Macia, E. et al. Dynasore, a cell-permeable inhibitor of dynamin. Dev. Cell 10, 839–850 (2006).
Cui, M., Tang, X., Christian, W. V., Yoon, Y. & Tieu, K. Perturbations in mitochondrial dynamics induced by human mutant PINK1 can be rescued by the mitochondrial division inhibitor mdivi-1. J. Biol. Chem. 285, 11740–11752 (2010).
Alaimo, A. et al. Deregulation of mitochondria-shaping proteins Opa-1 and Drp-1 in manganese-induced apoptosis. PLoS One 9, e91848 (2014).
Kim, D. I. et al. Abeta-Induced Drp1 phosphorylation through Akt activation promotes excessive mitochondrial fission leading to neuronal apoptosis. Biochim. Biophys. Acta 1863, 2820–2834 (2016).
Bido, S., Soria, F. N., Fan, R. Z., Bezard, E. & Tieu, K. Mitochondrial division inhibitor-1 is neuroprotective in the A53T-alpha-synuclein rat model of Parkinson’s disease. Sci. Rep. 7, 7495 (2017).
Wang, W. et al. Inhibition of mitochondrial fragmentation protects against Alzheimer’s disease in rodent model. Hum. Mol. Genet. 26, 4118–4131 (2017).
Maneechote, C. et al. Differential temporal inhibition of mitochondrial fission by Mdivi-1 exerts effective cardioprotection in cardiac ischemia/reperfusion injury. Clin. Sci. (Lond.) 132, 1669–1683 (2018).
Maimaitijiang, A., Zhuang, X., Jiang, X. & Li, Y. Dynamin-related protein inhibitor downregulates reactive oxygen species levels to indirectly suppress high glucose-induced hyperproliferation of vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 471, 474–478 (2016).
Lei, X. et al. Mitochondrial fission induces immunoescape in solid tumors through decreasing MHC-I surface expression. Nat. Commun. 13, 3882 (2022).
Whitley, B. N., Engelhart, E. A. & Hoppins, S. Mitochondrial dynamics and their potential as a therapeutic target. Mitochondrion 49, 269–283 (2019).
Guo, X. et al. Inhibition of mitochondrial fragmentation diminishes Huntington’s disease-associated neurodegeneration. J. Clin. Invest. 123, 5371–5388 (2013).
Medala, V. K. et al. Mitochondrial dysfunction, mitophagy, and role of dynamin-related protein 1 in Alzheimer’s disease. J. Neurosci. Res. 99, 1120–1135 (2021).
Ong, S. B., Kalkhoran, S. B., Cabrera-Fuentes, H. A. & Hausenloy, D. J. Mitochondrial fusion and fission proteins as novel therapeutic targets for treating cardiovascular disease. Eur. J. Pharmacol. 763, 104–114 (2015).
Rosdah, A. A. et al. A novel small molecule inhibitor of human Drp1. Sci. Rep. 12, 21531 (2022).
Naruse, G. et al. The intestine responds to heart failure by enhanced mitochondrial fusion through glucagon-like peptide-1 signalling. Cardiovasc. Res. 115, 1873–1885 (2019).
Torres, G. et al. Glucagon-like peptide-1 inhibits vascular smooth muscle cell dedifferentiation through mitochondrial dynamics regulation. Biochem. Pharmacol. 104, 52–61 (2016).
Lim, J. W., Lee, J. & Pae, A. N. Mitochondrial dysfunction and Alzheimer’s disease: prospects for therapeutic intervention. BMB Rep. 53, 47–55 (2020).
Masaldan, S., Callegari, S. & Dewson, G. Therapeutic targeting of mitophagy in Parkinson’s disease. Biochem. Soc. Trans. 50, 783–797 (2022).
Pei, H. et al. Melatonin prevents adverse myocardial infarction remodeling via Notch1/Mfn2 pathway. Free Radic. Biol. Med. 97, 408–417 (2016).
Wang, D. et al. A small molecule promotes mitochondrial fusion in mammalian cells. Angew. Chem. Int. Ed. Engl. 51, 9302–9305 (2012).
Maneechote, C. et al. Balancing mitochondrial dynamics via increasing mitochondrial fusion attenuates infarct size and left ventricular dysfunction in rats with cardiac ischemia/reperfusion injury. Clin. Sci. (Lond.) 133, 497–513 (2019).
Yue, W. et al. A small natural molecule promotes mitochondrial fusion through inhibition of the deubiquitinase USP30. Cell Res 24, 482–496 (2014).
Fu, F. et al. Punicalagin protects against diabetic cardiomyopathy by promoting Opa1-mediated mitochondrial fusion via regulating PTP1B-Stat3 pathway. Antioxid. Redox Signal. 35, 618–641 (2021).
Wang, K. et al. kappa-opioid receptor activation promotes mitochondrial fusion and enhances myocardial resistance to ischemia and reperfusion injury via STAT3-OPA1 pathway. Eur. J. Pharmacol. 874, 172987 (2020).
Wu, W. et al. OPA1 overexpression ameliorates mitochondrial cristae remodeling, mitochondrial dysfunction, and neuronal apoptosis in prion diseases. Cell Death Dis. 10, 710 (2019).
Gao, W. et al. NEFA-induced ROS impaired insulin signalling through the JNK and p38MAPK pathways in non-alcoholic steatohepatitis. J. Cell. Mol. Med. 22, 3408–3422 (2018).
Rad, S. M. A. et al. Metabolic and mitochondrial functioning in chimeric antigen receptor (CAR)-T Cells. Cancers 13, 1229 (2021).
Rostamian, H., Khakpoor-Koosheh, M., Fallah-Mehrjardi, K., Mirzaei, H. R. & Brown, C. E. Mitochondria as playmakers of CAR T-cell fate and longevity. Cancer Immunol. Res. 9, 856–861 (2021).
Douiev, L., Sheffer, R., Horvath, G. & Saada, A. Bezafibrate improves mitochondrial fission and function in DNM1L-deficient patient cells. Cells 9, 301 (2020).
Zhang, Y. et al. Enhancing CD8+ T cell fatty acid catabolism within a metabolically challenging tumor microenvironment increases the efficacy of melanoma immunotherapy. Cancer Cell 32, 377–391 e379 (2017).
Chowdhury, P. S., Chamoto, K., Kumar, A. & Honjo, T. PPAR-induced fatty acid oxidation in T cells increases the number of tumor-reactive CD8+ T cells and facilitates anti-PD-1 therapy. Cancer Immunol. Res. 6, 1375–1387 (2018).
Rostamian, H. et al. A metabolic switch to memory CAR T cells: Implications for cancer treatment. Cancer Lett. 500, 107–118 (2021).
Funk, C. R. et al. PI3Kdelta/gamma inhibition promotes human CART cell epigenetic and metabolic reprogramming to enhance antitumor cytotoxicity. Blood 139, 523–537 (2022).
Inoue-Yamauchi, A. & Oda, H. Depletion of mitochondrial fission factor DRP1 causes increased apoptosis in human colon cancer cells. Biochem. Biophys. Res. Commun. 421, 81–85 (2012).
Catanzaro, M. P. et al. Doxorubicin-induced cardiomyocyte death is mediated by unchecked mitochondrial fission and mitophagy. FASEB J. 33, 11096–11108 (2019).
Yin, M. et al. Silencing Drp1 inhibits glioma cells proliferation and invasion by RHOA/ ROCK1 pathway. Biochem. Biophys. Res. Commun. 478, 663–668 (2016).
Lin, X. H. et al. Suppressing DRP1-mediated mitochondrial fission and mitophagy increases mitochondrial apoptosis of hepatocellular carcinoma cells in the setting of hypoxia. Oncogenesis 9, 67 (2020).
Yu, Y. R. et al. Disturbed mitochondrial dynamics in CD8+ TILs reinforce T cell exhaustion. Nature immunology. Nat. Immunol. 20, 755–765 (2018).
Eisner, V., Picard, M. & Hajnoczky, G. Mitochondrial dynamics in adaptive and maladaptive cellular stress responses. Nat. Cell Biol. 20, 755–765 (2018).
Tur, J., Vico, T., Lloberas, J., Zorzano, A. & Celada, A. Macrophages and mitochondria: a critical interplay between metabolism, signaling, and the functional activity. Adv. Immunol. 133, 1–36 (2017).
Ishihara, N. et al. Mitochondrial fission factor Drp1 is essential for embryonic development and synapse formation in mice. Nat. Cell Biol. 11, 958–966 (2009).
Jin, J. Y., Wei, X. X., Zhi, X. L., Wang, X. H. & Meng, D. Drp1-dependent mitochondrial fission in cardiovascular disease. Acta Pharmacol. Sin. 42, 655–664 (2021).